Franklin Genomic Advancements ETF
HELX
HELX
5 hedge funds and large institutions have $439K invested in Franklin Genomic Advancements ETF in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$1.76M | |
| 2 | -$389K | |
| 3 | -$41.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$23.9K |
| 5 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$1.52K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
LPL Financial
San Diego,
California
| $282K |
|
|||
2
Osaic Holdings
Scottsdale,
Arizona
| $95.5K |
|
|||
|
HI
3
Harbour Investments
Madison,
Wisconsin
| $49.9K |
|
|||
|
HHGA
4
Halbert Hargrove Global Advisors
Long Beach,
California
| $12.4K |
|
|||
5
Morgan Stanley
New York
| $50 |
|
|||
6
JP Morgan Chase
New York
| $1 |
|
|||
7
Citadel Advisors
Miami,
Florida
| – |
|
|||
8
Raymond James Financial
St Petersburg,
Florida
| – |
|
|||
|
9
UBS Group
Zurich,
Switzerland
| – |
|